Please disable your adblock and script blockers to view this page

Bristol-Myers Is Buying Celgene for $74 Billion in One of the Largest Big Pharma Mergers Ever


Bristol-Myers Squibb
Celgene
Merck
Keytruda
Juno Therapeutics
The U.S. Food and Drug Administration


Celgene
Giovanni Caforio
Revlimid

No matching tags

No matching tags

No matching tags


New York
Bristol
Celgene
New Jersey

No matching tags

Positivity     37.00%   
   Negativity   63.00%
The New York Times
SOURCE: http://fortune.com/2019/01/03/bristol-myers-celgene-merger/
Write a review: Fortune
Summary

The deal unites two cancer-drug makers in one of the largest pharmaceutical-company mergers ever.

As said here by Bloomberg